Correction to: A DELPHI consensus statement on antiplatelet management for intracranial stenting due to underlying atherosclerosis in the setting of mechanical thrombectomy (Neuroradiology, (2021), 63, 4, (627-632), 10.1007/s00234-020-02556-z)

  • Mayank Goyal
  • , Kirill Orlov
  • , Mary E. Jensen
  • , Allan Taylor
  • , Charles Majoie
  • , Mahesh Jayaraman
  • , Jianmin Liu
  • , Geneviève Milot
  • , Patrick Brouwer
  • , Shinichi Yoshimura
  • , Felipe Albuquerque
  • , Adam Arthur
  • , David Kallmes
  • , Nobuyuki Sakai
  • , Justin F. Fraser
  • , Raul Nogueira
  • , Pengfei Yang
  • , Franziska Dorn
  • , Lucie Thibault
  • , Jens Fiehler
  • René Chapot, Johanna Maria Ospel

Research output: Contribution to journalComment/debate

Abstract

The publisher would like to correct an error in Supplementary table I: Consensus recommendations for the dosage of GPIIb/IIIa receptor inhibitors* Please note the Eptifibatide dosing is incorrect. The correct dose is 2 mcg/kg/min.

Original languageEnglish
Pages (from-to)1391-1392
Number of pages2
JournalNeuroradiology
Volume63
Issue number8
DOIs
StatePublished - Aug 2021

Bibliographical note

Publisher Copyright:
© 2021, Springer-Verlag GmbH Germany, part of Springer Nature.

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Correction to: A DELPHI consensus statement on antiplatelet management for intracranial stenting due to underlying atherosclerosis in the setting of mechanical thrombectomy (Neuroradiology, (2021), 63, 4, (627-632), 10.1007/s00234-020-02556-z)'. Together they form a unique fingerprint.

Cite this